Genentech to Appeal to F.D.A. for Breast Cancer Drug
Monday, June 27, 2011 - 00:10
in Health & Medicine
Genentech will ask the F.D.A. to rethink its proposal to revoke the approval of Avastin for breast cancer on the grounds that new studies did not confirm that the drug helped patients.